BCL2 and hepatocellular carcinoma: Our studies showed that compound 1 could decrease the expression of anti-apoptotic Bcl-2 (Figure 5a,b) and increase the expression of pro-apoptotic BAX, while also increasing the Bax/Bcl-2 ratio in HCC cells.